Stanislav Gobec Selected Research

Stanislav Gobec Research Topics

Disease

29	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 10/2014
24	Neoplasms (Cancer) 01/2024 - 03/2006
10	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2006
9	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2023 - 03/2015
4	Neoplasm Metastasis (Metastasis) 12/2020 - 08/2015
3	Pathologic Processes 01/2022 - 08/2015
3	Endometriosis 05/2012 - 01/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 10/2019
2	Parkinson Disease (Parkinson's Disease) 05/2023 - 05/2022
2	Neuroblastoma 01/2022 - 01/2021
2	Necrosis 01/2021 - 01/2000
2	Prostatic Neoplasms (Prostate Cancer) 05/2020 - 03/2006
2	Fibrosarcoma 08/2017 - 08/2015
2	Sepsis (Septicemia) 01/2016 - 01/2013
2	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2014 - 01/2012
2	Endometrial Neoplasms (Endometrial Cancer) 03/2009 - 03/2006
1	Communicable Diseases (Infectious Diseases) 01/2024
1	COVID-19 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2022
1	Stroke (Strokes) 08/2022
1	Glioblastoma (Glioblastoma Multiforme) 02/2022
1	Glioma (Gliomas) 02/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Cognitive Dysfunction 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Virus Diseases (Viral Diseases) 10/2019
1	Cardiotoxicity 08/2019
1	Dementia (Dementias) 11/2018

Drug/Important Bio-Agent (IBA)

11	LigandsIBA 05/2023 - 11/2014
10	ButyrylcholinesteraseIBA 05/2023 - 10/2014
10	Cathepsin BIBA 01/2023 - 01/2013
9	Cysteine (L-Cysteine)FDA Link 01/2023 - 11/2016
8	nitroxolineIBA 01/2023 - 01/2013
8	Hormones (Hormone)IBA 04/2013 - 03/2006
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2013
6	CathepsinsIBA 01/2023 - 01/2017
6	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 11/2016
5	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2018
5	Cholinesterases (Cholinesterase)IBA 05/2023 - 03/2016
5	AntioxidantsIBA 08/2022 - 05/2016
5	EnzymesIBA 01/2022 - 08/2016
4	Oxidoreductases (Dehydrogenase)IBA 05/2023 - 11/2011
4	Cholinergic Agents (Cholinergics)IBA 11/2022 - 12/2016
3	Anti-Infective Agents (Microbicides)IBA 01/2023 - 08/2017
3	CarboxypeptidasesIBA 02/2022 - 01/2017
3	Monoamine Oxidase (MAO)IBA 01/2022 - 01/2017
3	AmidesIBA 09/2020 - 08/2016
3	Aldo-Keto ReductasesIBA 02/2013 - 03/2009
3	Estrogens (Estrogen)FDA Link 04/2011 - 03/2006
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2024 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2021
2	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 03/2019
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2022 - 03/2021
2	Antineoplastic Agents (Antineoplastics)IBA 09/2019 - 06/2009
2	CollagenIBA 01/2018 - 08/2015
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2016 - 05/2016
2	Toll-Like Receptor 4IBA 01/2016 - 01/2013
2	Estrogen ReceptorsIBA 08/2013 - 03/2009
2	cinnamic acidIBA 08/2013 - 03/2009
1	Fluorescent Dyes (Fluorescent Probes)IBA 05/2024
1	Free Radical ScavengersIBA 05/2023
1	AcetylcholinesteraseIBA 05/2023
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 05/2023
1	Chelating AgentsIBA 05/2023
1	Trace Elements (Biometals)IBA 05/2023
1	Oxidopamine (6 Hydroxydopamine)IBA 05/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023
1	IonsIBA 11/2022
1	CopperIBA 11/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022
1	nitronesIBA 08/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 02/2022
1	TriazolesIBA 01/2022
1	DioxinsIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	KynurenineIBA 01/2022
1	ElastinIBA 01/2022
1	Monobactams (Monobactam Antibiotics)IBA 03/2021
1	AnticoagulantsIBA 03/2021
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 03/2021
1	ethyleneIBA 01/2021
1	IndazolesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Antiparkinson Agents (Antiparkinsonian Agents)IBA 01/2021
1	tolserineIBA 09/2020
1	cymserineIBA 09/2020
1	AcidsIBA 09/2020
1	AminesIBA 09/2020
1	phenserineIBA 09/2020
1	MetalsIBA 02/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 08/2019
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2019
1	PoisonsIBA 08/2019
1	Scopolamine (Hyoscine)FDA Link 11/2018

Therapy/Procedure

18	Therapeutics 05/2023 - 01/2011
1	Immunomodulation 03/2021